Matinas BioPharma(MTNB)
$0.90-0.02 (-1.96%)
MTNB
Matinas BioPharma earnings date
$0.90
At close:-0.02 (-1.96%)
Want to see MTNB full AI Analyst Report?
Matinas BioPharma (MTNB) Q2 2022 Earnings Report
1,546 Followers
MTNB Q2 2022 EPS Results
- Actual EPS
- -$1.50
- Consensus EPS
- -$1.68
- Beat/Miss
- Beat by +$0.18
- One Year Ago EPS
- -$1.00
MTNB Q2 2022 Revenue Results
- Actual Revenue
- $1.06M
- Expected Revenue
- $83.00K
- Beat/Miss
- Beat by +$979.50K
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/11/2022
- Time
- Before Open
- Conference Call
- Thursday, August 11, 2022
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
MTNB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| May 07, 2026 | 2026 (Q1) | ―-0.30 | -0.33 | 7.98% (+0.03) | |
| Aug 19, 2025 | 2025 (Q2) | ―-1.03 | -1 | -3.10% (-0.03) | |
| May 08, 2025 | 2025 (Q1) | ―-0.33 | -1.5 | 78.27% (+1.17) | |
| Mar 18, 2025 | 2024 (Q4) | -0.78-1.66 | -1 | -65.80% (-0.66) | |
| Nov 06, 2024 | 2024 (Q3) | -1.05-0.85 | -1.5 | 43.33% (+0.65) | |
| Aug 14, 2024 | 2024 (Q2) | -18.75-15.00 | -22.5 | 33.33% (+7.50) | |
| May 09, 2024 | 2024 (Q1) | -22.50-22.50 | -22.5 | 0.00% (+0.00) | |
| Mar 27, 2024 | 2023 (Q4) | -22.50-15.00 | -15 | 0.00% (+0.00) | |
| Nov 08, 2023 | 2023 (Q3) | -21.79-22.50 | -22.5 | 0.00% (+0.00) | |
| Aug 09, 2023 | 2023 (Q2) | -22.76-22.50 | -22.5 | 0.00% (+0.00) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
